Link Pharmachem

Pharmaceuticals & Drugs
₹27
+6.64%
Prev close ₹25.32
Get AI-Powered Analysis for Link Pharmachem Free Analysis → FREE View live price, charts & full analysis for Link Pharmachem →

Link Pharmachem Share Price Chart

Link Pharmachem last traded at ₹27.00 (2026-10-13). Over the past month the stock moved -1.6%, three months the stock moved -3.6%, year the stock moved -23.0%. Its closing range over 52 weeks is ₹22.64 – ₹35.06, with the latest close 23.0% below the high.

Closing prices up to 2026-10-13.

About Link Pharmachem

Incorporated in 1986, Link Pharma Chem Ltd is in the business of manufacturing and job work of organic intermediate[1]

Business Overview:[1][2] LPCL is engaged in the manufacturing and selling of organic /drug intermediates for Pharma, Agriculture, Cosmetics, Speciality Chemicals, and Veterinary industries.

Fundamentals

Market Cap₹12.59 Cr
52W High₹41.90
52W Low₹21
P/E Ratio-2835
P/B Ratio0.96
EPS₹-0.01
Dividend Yield0%
ROE (3yr)-6%
Sales Growth (3yr)-11%
Profit Growth (3yr)-48%

Quarterly Results

In the latest quarter (Jun 2026), Link Pharmachem reported sales of ₹8.77 crore (+12.3%) and net profit of ₹0.32 crore (-20.0%), compared with the same quarter last year.

Link Pharmachem quarterly results (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Jun 20268.770.455.130.320.72
Mar 20266.59-0.24-3.64-0.41-0.92
Dec 20256.730.6910.250.070.16
Sep 20256.290.345.410.020.05
Jun 20257.810.648.190.400.90
Mar 20256.45-0.23-3.57-0.35-0.79
Dec 20245.340.112.06-0.67-1.51
Sep 20244.80-0.30-6.25-0.31-0.70
Year-on-year change vs the same quarter last year
Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales growth-20.7%-32.7%-19.7%-11.8%+31.0%+26.0%+2.2%+12.3%
Operating profit growth–-60.7%-125.3%+16.4%–+527.3%–-29.7%
Net profit growth–-404.5%-234.6%+33.3%–––-20.0%
EPS growth–-402.0%-233.9%+32.4%–––-20.0%
OPM %-6.3%2.1%-3.6%8.2%5.4%10.3%-3.6%5.1%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Annual Financials

In the latest year (Mar 2026), Link Pharmachem reported sales of ₹27.43 crore (+7.9%) and net profit of ₹0.08 crore, compared with the previous year.

Link Pharmachem annual profit & loss (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 202627.431.455.290.080.18
Mar 202525.430.130.51-1.03-2.32
Mar 202429.90-0.65-2.17-1.36-3.06
Mar 202338.762.727.020.651.46
Mar 202253.563.546.611.884.23
Mar 202134.813.149.021.082.43
Mar 202025.473.4213.430.952.14
Mar 201924.502.028.240.661.49
Year-on-year change vs the previous year
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales growth+4.1%+4.0%+36.7%+53.9%-27.6%-22.9%-14.9%+7.9%
Operating profit growth-27.3%+69.3%-8.2%+12.7%-23.2%-123.9%–+1015.4%
Net profit growth-41.6%+43.9%+13.7%+74.1%-65.4%-309.2%––
EPS growth-41.3%+43.6%+13.6%+74.1%-65.5%-309.6%––
OPM %8.2%13.4%9.0%6.6%7.0%-2.2%0.5%5.3%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Shareholding

Promoter Holding52.40%

AI Analysis

No AI analysis generated yet for Link Pharmachem.

Get Free AI Stock Analysis FREE →

Latest News

No recent news available for Link Pharmachem.

Frequently Asked Questions

What is the share price of Link Pharmachem today?

Link Pharmachem shares were last quoted at ₹27.00 (+6.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.

What is the P/E ratio of Link Pharmachem?

Link Pharmachem has a price-to-earnings (P/E) ratio of -2,835.00 and a price-to-book (P/B) ratio of 0.96. The industry P/E is 54.21.

What is the 52-week high and low of Link Pharmachem?

The 52-week high of Link Pharmachem is ₹41.90 and the 52-week low is ₹21.00.

What is the market cap of Link Pharmachem?

The market capitalisation of Link Pharmachem is about ₹12.59 crore.

How did Link Pharmachem perform in its latest quarterly results?

In the latest quarter (Jun 2026), Link Pharmachem reported sales of ₹8.77 crore (+12.3%) and net profit of ₹0.32 crore (-20.0%), compared with the same quarter last year.

Is Link Pharmachem a good stock to buy?

This page is for information and is not investment advice. As per the data shown here, Link Pharmachem has a 3-year ROE of -6.00%, 3-year profit growth of -48.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.

What is the promoter holding in Link Pharmachem?

Promoters hold about 52.40% of Link Pharmachem.

Which sector does Link Pharmachem belong to?

Link Pharmachem belongs to the Pharmaceuticals & Drugs sector.

Other Pharmaceuticals & Drugs stocks

All Pharmaceuticals & Drugs stocks · Browse all stocks A–Z

Go to live page for Link Pharmachem →